Conference Call Transcripts

BioScrip, Inc. Q1 2010 Earnings Call Transcript
April 30, 2010 | Source: Seeking Alpha

BioScrip, Inc. Q4 2009 Earnings Call Transcript
Feb. 26, 2010 | Source: Seeking Alpha

BioScrip Inc. Q3 2009 Earnings Call Transcript
Oct. 30, 2009 | Source: Seeking Alpha

BioScrip, Inc. Q2 2009 Earnings Call Transcript
July 30, 2009 | Source: Seeking Alpha

BioScrip Inc. Q1 2009 Earnings Call Transcript
May 4, 2009 | Source: Seeking Alpha

BioScrip Inc. Q4 2008 Earnings Call Transcript
March 3, 2009 | Source: Seeking Alpha

BioScrip, Inc. Q2 2008 Earnings Call Transcript
Aug. 21, 2008 | Source: Seeking Alpha

BioScrip, Inc. Q4 2007 Earnings Call Transcript
March 19, 2008 | Source: Seeking Alpha

Recent filings

Securities registration termination [Section 12(g)] - Oct. 16, 2023

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities - Oct. 6, 2023

Registration Withdrawal Request - Oct. 4, 2023

BioScrip: Termination And Release Agreement, Dated October 4, 2023, By And Among Bioplus Acquisition Corp., Guardian Merger Subsidiary Corp., Avertix Medical, Inc., And Bioplus Sponsor Llc - Oct. 4, 2023

Prospectuses and communications, business combinations - Sept. 15, 2023

Prospectuses and communications, business combinations - Aug. 16, 2023

BioScrip Just Filed Its Quarterly Report: Net Income (Loss) pe... - Aug. 14, 2023

Registration of securities, business combinations - Aug. 1, 2023

Prospectuses and communications, business combinations - July 17, 2023

Registration of securities, business combinations - June 30, 2023

Alex Vieux just provided an update on activist position in BioScrip - June 13, 2023

Major owner of BioScrip just picked up 5,749,999 shares - June 12, 2023

Entry into a Material Definitive - June 8, 2023

Prospectuses and communications, business combinations - May 30, 2023

Current report, items 7.01 and 9.01 - May 30, 2023

Prospectuses and communications, business combinations - May 19, 2023

Registration of securities, business combinations - May 15, 2023

Other definitive proxy statements - May 12, 2023

Prospectuses and communications, business combinations - May 3, 2023

Current report, items 1.01, 7.01, and 9.01 - May 3, 2023

Other preliminary proxy statements - April 27, 2023

BioScrip Just Filed Its Annual Report: Net Income (Loss) Pe... - March 31, 2023

Saba Capital Management GP, LLC just provided an update on share ownership of BioScrip - Feb. 14, 2023

Howard W. Lutnick just provided an update on share ownership of BioScrip - Feb. 14, 2023

Statement of acquisition of beneficial ownership by individuals - Feb. 9, 2023

Highbridge Capital Management, LLC just provided an update on share ownership of BioScrip - Feb. 2, 2023

BioScrip Just Filed Its Quarterly Report: Net Income (Loss) pe... - Nov. 3, 2022

Howard W. Lutnick just provided an update on share ownership of BioScrip - Nov. 2, 2022

BioPlus Acquisition - Oct. 11, 2022

BioScrip Just Filed Its Annual Report: Net Income (Loss) Pe... - March 11, 2022

Saba Capital Management GP, LLC just provided an update on share ownership of BioScrip - Feb. 14, 2022

MM Asset Management Inc. just provided an update on share ownership of BioScrip - Feb. 9, 2022

Alex Vieux just provided an update on activist position in BioScrip - Dec. 17, 2021

BioScrip: Index To Financial Statements - Dec. 13, 2021

Saba Capital Management GP, LLC just provided an update on share ownership of BioScrip - Dec. 13, 2021

Highbridge Capital Management, LLC just provided an update on share ownership of BioScrip - Dec. 10, 2021

MM Asset Management Inc. just provided an update on share ownership of BioScrip - Dec. 10, 2021

BioScrip: Bioplus Acquisition Corp. Announces Pricing Of Upsized $200,000,000 Initial Public Offering - Dec. 8, 2021

Major owner of BioScrip just disposed of 675,294 shares - Nov. 15, 2021

Major owner of BioScrip just disposed of 618,299 shares - Nov. 15, 2021

Prospectus [Rule 424(b)(7)] - Nov. 10, 2021

BioScrip Just Filed Its Quarterly Report: EARNINGS (LOSS) PER ... - Nov. 4, 2021

BioScrip: Option Care Health Announces Financial Results For The Third Quarter Ended September 30, 2021 - Nov. 4, 2021

Entry into a Material Definitive - Oct. 29, 2021

BioScrip's CHIEF EXECUTIVE OFFICER was just granted 122,134 options and restricted shares - Oct. 28, 2021

BioScrip: Option Care Health Announces Pricing Of Offering Of $500 Million 4.375% Senior Notes And Amendment And Extension Of First Lien Term Loan - Oct. 25, 2021

BioScrip's CHIEF COMMERCIAL OFFICER was just granted 54,364 options and restricted shares - Oct. 25, 2021

BioScrip's CHIEF FINANCIAL OFFICER was just granted 66,445 options and restricted shares - Oct. 25, 2021

BioScrip: Option Care Health Announces Offering Of $500 Million Of Senior Notes And Amendment And Extension Of First Lien Term Loan - Oct. 20, 2021

BioScrip: Option Care Health Announces Preliminary Financial Results For The Third Quarter Ended September 30, 2021 And Schedules Third Quarter Earnings Call - Oct. 20, 2021

Departure of Directors or Certain - Sept. 22, 2021

Major owner of BioScrip just disposed of 618,299 shares - Sept. 21, 2021

Samuel M. Mencoff just provided an update on activist position in BioScrip - Sept. 13, 2021

Major owner of BioScrip just disposed of 9,200,000 shares - Sept. 10, 2021

Prospectus [Rule 424(b)(4)] - Sept. 9, 2021

On September - Sept. 9, 2021

BioScrip's CHIEF OPERATING OFFICER was just granted 125,974 options - Aug. 24, 2021

BioScrip's CHIEF OPERATING OFFICER was just granted 171,367 options and restricted shares - Aug. 23, 2021

BioScrip's Chief Medical Officer just declared ownership of no shares of BioScrip - Aug. 19, 2021

BioScrip's Chief Medical Officer was just granted 19,292 restricted shares - Aug. 19, 2021

BioScrip director just picked up 50,000 shares - Aug. 18, 2021

Departure of Directors or Certain - Aug. 16, 2021

Major owner of BioScrip just disposed of 20,700,000 shares - Aug. 6, 2021

Samuel M. Mencoff just provided an update on activist position in BioScrip - Aug. 6, 2021

Prospectus [Rule 424(b)(4)] - Aug. 5, 2021

On August - Aug. 5, 2021

BioScrip: Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2021 - Aug. 3, 2021

BioScrip Just Filed Its Quarterly Report: EARNINGS (LOSS) PER ... - Aug. 3, 2021

BioScrip's CHIEF STRATEGY OFFICER just picked up 32,380 shares - July 13, 2021

BioScrip's CHIEF FINANCIAL OFFICER just picked up 15,816 shares - July 13, 2021

BioScrip's CHIEF EXECUTIVE OFFICER just picked up 52,716 shares - July 13, 2021

BioScrip's CHIEF OPERATING OFFICER just picked up 48,440 shares - July 13, 2021

BioScrip's CHIEF ACCOUNTING OFFICER just picked up 2,504 shares - July 13, 2021

BioScrip's SEE REMARKS just picked up 5,272 shares - July 13, 2021

Major owner of BioScrip just disposed of 17,250,000 shares - June 14, 2021

Samuel M. Mencoff just provided an update on activist position in BioScrip - June 14, 2021

Major owner of BioScrip just disposed of 17,250,000 shares - June 14, 2021

Statement of changes in beneficial ownership of securities - June 14, 2021

On June - June 10, 2021

Prospectus [Rule 424(b)(4)] - June 10, 2021

BioScrip director just picked up 13,428 shares - May 28, 2021

Statement of changes in beneficial ownership of securities - May 28, 2021

BioScrip director just picked up 16,650 shares - May 28, 2021

Statement of changes in beneficial ownership of securities - May 28, 2021

BioScrip director just picked up 13,851 shares - May 28, 2021

BioScrip director just picked up 13,626 shares - May 28, 2021

Current report, item 5.07 - May 21, 2021

BioScrip director just picked up 40,000 shares - May 20, 2021

BioScrip director just picked up 855 shares - May 12, 2021

BioScrip's CHIEF FINANCIAL OFFICER just picked up 2,500 shares - May 12, 2021

Statement of changes in beneficial ownership of securities - May 12, 2021

Sorry, no schedule available for this company

BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate - Oct. 4, 2023

Coliseum Nominates Slate of Highly Qualified and Engaged Director Candidates for Election at Purple Innovation 2023 Annual Meeting - Feb. 13, 2023

BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering - Dec. 6, 2021

BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering - Dec. 2, 2021

BioScrip (BIOS)

Recent filings

Sorry, no schedule available for this company

Provide Feedback